德国Bayer公司在美国的子公司Miles公司正在按照预定的计划扩建它在Baytown的马来酸酐装置,第一台反应器已在五月份安装完,最近又安装好第二台反应器。估计该装置将于今年10月份建成,年末即可投入运转。新装置的能力将为现有装置的近三倍,它建成后使该公司的马来酸酐能力达到8万多吨/年。 Miles, a subsidiary of Bayer in the United States, is expanding its maleic anhydride unit in Baytown according to a schedule. The first reactor has been installed in May and the second reactor has recently been installed. It is estimated that the device will be completed in October this year and will be put into operation by the end of the year. The capacity of the new device will be nearly three times that of the existing device. After its completion, the company’s capacity for maleic anhydride will reach more than 80,000 tons per year.